[1]
Ciotti, S. , Micheli, M., Cometa, A., De Carlo, C. , Martini, G., Marona, A. , Filippetti, L., Carducci, D. , Baratta, S., Zampolini, M. and Corea, F. 2021. Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health. European Journal of Case Reports in Internal Medicine. 8, 9 (Oct. 2021). DOI:https://doi.org/10.12890/2021_002298.